Building Companies
The OBIO® Capital Access Advisory Program (CAAP®) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. OBIO’s CAAP® creates high value deal flow for both companies and investors, and opportunity to participate at the OBIO® Investment Summit and other international investment conferences.
What is OBIO’s CAAP®?
A competitive, 9-12 month structured program for health science companies starting to raise a post-seed financing round over the next 12-18 months.
CAAP® covers three fundamental business themes:
Business strategic planning & increasing the ROI for investors
Advanced fundraising strategies
Closing an investment round and business development contract
Benefits for CAAP® companies:
Strategic Connections: Receive warm introductions and strategic guidance to venture investors, healthcare executives and business experts customized to your business strategy
Lead Generation: Leverage support from the OBIO® team to reach out to VCs and strategic partners at international conferences to generate new leads
Valuable Network Access: Get connected with the CAAP® and EAHN® alumni network of founders, as well as executive teams from OBIO® companies that have successfully closed financing
Continuous Support: Enjoy ongoing support throughout your company’s journey, become a CAAP® alumnus
Eligibility requirements:
Be a private, high-potential bioscience company based in Ontario
Focus on developing human health science products including but not limited to: therapeutics, medical devices, diagnostics or digital health technologies
Starting to raise a post-seed financing round in the next 12-18 months
Have enough resources and funding runway to reach key value inflection points
Chief Executive Officer and/or other members of the senior management team of each company admitted into the program must be actively engaged in the program. This includes participation in CAAP® specific workshops and other events throughout the CAAP® term
CAAP® culminates with a presentation at the OBIO® Investment Summit (OIS):
• Present to and meet with global health sciences investors & strategics
• > $3B raised by Summit companies since 2018
• 275+ companies have presented at the Summit
Applications close on April 30, 2026.
Please note that only selected companies will be contacted to move on to the next stage of application.
Have a question? Contact us:
Parnian Tajbakhsh
Senior Manager, Capital Access
parniantajbakhsh@obio.ca
CAAP® Companies 2024-2025
CAAP® Companies 2023
CAAP® Companies 2022
CAAP® Companies 2021
CAAP® Companies 2020
CAAP® Companies 2019
FUNDED BY THE GOVERNMENT OF CANADA.